A Pharmaceutical composition which inhibits aldose reductase enzymes is disclosed. In the composition, a hydantoin derivative known per se is uniformly dispersed in a high molecular carrier for the hydantoin derivative. The composition may further contain a water soluble high molecular substance. The composition is administered to prevent or cure complications due to diabetes.
